Halozyme Therapeutics Inc. (HALO)

$ 100.27
   
  • Change Today:
    $-0.40
  • 52 Week High: $133.74
  • 52 Week Low: $61.70
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 2,276,409
  • Market Cap: $14,569m
  • RiskGrade: 189

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 1,887.12 1,102.68 888.00¢ 11.3 n/a n/a n/a 0.0%
31-Dec-27 2,154.27 1,358.76 1,071.72¢ 9.4 0.5 +21% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 100.27
Change Today $ -0.40
% Change -0.40 %
52 Week High $133.74
52 Week Low $61.70
Volume 2,276,409
Shares Issued 145.30m
Market Cap $14,569m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 3
Sell 0
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Nov-2026

Time Volume / Share Price
15:59 100 @ $100.29
15:59 100 @ $100.29
15:59 100 @ $100.30
15:59 100 @ $100.30
15:59 100 @ $100.29

Top of Page